Lab-grown mini brains may predict which Alzheimer’s treatments will work
Scientists at Johns Hopkins Medicine discovered that lab-grown brain organoids from Alzheimer's patients could predict responses to psychiatric medications. This research supports the potential for personalized treatments and identifies extracellular vesicles as new biomarkers for diagnosing and staging Alzheimer's disease. The findings, published in Alzheimer's & Dementia, highlight the importance of these models in understanding treatment efficacy for neuropsychiatric symptoms.